3Spitsbergen JM,Stewart JS,Tuttle JB.Altered regulation of nerve growth factor secretion by cultured VSMCs from hypertensive rats.Am J Physiol,1995,269(2 Pt 2):H621-H628.
4Tabei R,Kondo M,Terada M,et al.Noradrenergic hyperinnervation in the caval vein of stroke-prone spontaneously hypertensive rats.Clin Exp Pharmacol Physiol Suppl,1995,22:S73-S74.
5Coutard M,Mertes P,Mairose P,et al.Arterial sympathetic innervation and cerebrovascular diseases in original rat models.Auton Neurosci,2003,104:137-145.
6Kondo M,Fujiwara T,Tabei R.Noradrenergic hyperinnervation in the heart of stroke-prone spontaneously hypertensive rats (SHRSP).Hypertens Res,1996,19:69-73.
7Lohmeier TE.The sympathetic nervous system and long-term blood pressure regulation.Am J Hypertens,2001,14(6 Pt 2):147S-154S.
8Charchar FJ,Kapuscinski M,Harrop SB.Persistent reduction in renal nerve growth factor mRNA after perindopril treatment of young spontaneously hypertensive rats.Hypertension,1998,31:678-683.
9Sherer TB,Neff PS,Hankins GR,et al.Mechanisms of increased NGF production in vascular smooth muscle of the spontaneously hypertensive rat.Exp Cell Res,1998,241:186-193.
5Sternini C, Brecha N. Distributon and colocalization of neuropeptide Y-and Tyrosine-hydroxylase-like immunoreactivity in the guinea-pig heart[J]. Cell Tiss Res,1985,241:93-102.
6Kawamura K,Sakata N,Takebayashi S. Neuropeptide Y and vasoactive intestinal polypeptide containing nerve fibers in the human cerebral artedes:characteristics of distribution [J]. Angiology,1991,42(1) : 35-43.
7Tuor UI, Kelly PAT, Edvinsson L, et ak Neuropeptide Y and the cerebral circulation[J]. J Cereb Blood Flow Metab, 1990,10: 591-601.
8Shu S,Ju G,Fan L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system[J]. Neuroscience Letters, 1988,85:169-171.
9Kobayashi S, Kyoshima K, Olschowka JA, et al. Vasoactive intestinal polypeptide immunoreactive and cholinergic nerves in the whole mount preparation of the major cerebral arteries of the rat[J]. Hitochemistry, 1983,79 (2) : 377-381.
10Mione MC,Dhital KK, Amenta F, et ak Increase in the expression of nerve peptidergic vasodilator, but not vasoconstricutor, cerebrovascular nerves in aging rats[J]. Brain Res, 1988,460:103- 113.
2Ejim E C,Okafor C I,Emehel A,et al.Prevalence ofcardiovascular risk factors in the middle-aged and elderlypopulation of a nigerian rural community[J].J Trop Med,2011,2011:308687.Epub2011.
5Su B C,Yu H P,Yang M V,et al.Reliability of a newultrasonic cardiac output monitor in recipients of living donorliver transplantation[J].Liver Transpl,2008,14(7):1029-1037.
6Onat A,Can G,Ornek E,et al.Serumγ-Glutamyltransferase:Independent Predictor of Risk of Diabetes,Hypertension,Metabolic syndrome,and Coronary Disease[J].Obesity(SilverSpring),2011.
7Ong K T,Delerme S,Pannier B,et al.Aortic stiffness isreduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment:a meta-analysis of individualdata in294patients[J].J Hypertens,2011,29(6):1034-1042.
8Kalay N,Yarlioglues M,Ardic I,et al.The assessment ofatherosclerosis on vascular structures in patients with acutecoronary syndrome[J].Clin Invest Med,2010,33(1):E36-43.
9Pocanic D.The role of endothelium in hypertension andatherosclerosis[J].Lijec Vjesn,2006,128(11-12):396-398.
10Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol, 2003 ;81:533 - 541
